End Stage Renal Disease (ESRD) is a medical condition in which the kidneys are no longer able to adequately filter waste from the blood. It is a major cause of morbidity and mortality in the U.S. and is managed by Urologists and Nephrologists. Treatment options for ESRD include dialysis, kidney transplantation, and conservative management. Dialysis is the most common treatment for ESRD and is used to replace the function of the kidneys. Kidney transplantation is the most effective treatment for ESRD, but is limited by the availability of donor organs. Conservative management is used to slow the progression of ESRD and improve quality of life.
The ESRD market is a rapidly growing sector of the healthcare industry. It is driven by an aging population, increasing prevalence of chronic kidney disease, and advances in dialysis technology. Companies in the ESRD market include Fresenius Medical Care, DaVita, Baxter International, NxStage Medical, and B. Braun Melsungen. Show Less Read more
